INMUNE BIO INC. Investing Cash Flow
INMUNE BIO INC. (INMB) reported Investing Cash Flow of -$430.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- INMUNE BIO INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$143.00K.
- INMUNE BIO INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$193.00K.
- INMUNE BIO INC. net cash provided by (used in) investing activities for the quarter ending 2021-12-31 was $0.00.
- INMUNE BIO INC. net cash provided by (used in) investing activities for the quarter ending 2021-09-30 was $0.00.
- INMUNE BIO INC. net cash provided by (used in) investing activities for fiscal 2025 was -$1.04M.
- INMUNE BIO INC. net cash provided by (used in) investing activities for fiscal 2021 was -$15.00M.
- INMUNE BIO INC. net cash provided by (used in) investing activities for fiscal 2017 was -$100.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$430.00K 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | -$143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$336.00K derived: sum of 2 quarters · filed 2026-03-30 | -$1.04M 10-K · filed 2026-03-30 | |
| 2025-09-30 | -$193.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$899.00K 10-Q · filed 2025-10-30 | ||
| 2025-06-30 | -$706.00K 10-Q · filed 2026-08-06 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | -$15.00M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$15.00M 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | -$15.00M 10-Q · filed 2022-08-03 | |||
| 2017-12-31 | -$100.00K 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |